Literature DB >> 19186204

Appearance of skin lesions in cattle populations vaccinated against lumpy skin disease: statutory challenge.

J Brenner1, M Bellaiche, E Gross, D Elad, Z Oved, M Haimovitz, A Wasserman, O Friedgut, Y Stram, V Bumbarov, H Yadin.   

Abstract

The ultimate goal of a vaccine is to protect vaccinated animals against re-exposure to the same pathogen and provide sterile immunity. However, a cutaneous clinical manifestation appeared, following re-exposure of cattle that had been vaccinated with the RM65 strain, to LSDV infection during an epidemic in 2006-2007. Four thousand six hundred and seven vaccinated cows entered the study after being re-exposed to LSDV infection. Of them, 513 (11%) presented lumps, and there was a marked difference between the proportions of dairy and feedlot animals that were affected: 146 out of 3517 and 367 out of 1090 (6.6 and 33.7%, respectively). This data suggests that the potency of the vaccine need to be re-assessed for beef cattle.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19186204     DOI: 10.1016/j.vaccine.2009.01.020

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  Sequence analysis of attachment gene of lumpy skin disease and sheep poxviruses.

Authors:  A A El-Kenawy; M S El-Tholoth
Journal:  Virol Sin       Date:  2010-12-21       Impact factor: 4.327

2.  Molecular and histopathological characterization of lumpy skin disease in cattle in northern Vietnam during the 2020-2021 outbreaks.

Authors:  Thi Bich Ngoc Trinh; Van Tam Nguyen; Thi Thu Huyen Nguyen; Nguyen Tuan Anh Mai; Phuong Nam Le; Thi Ngoc Ha Lai; Thanh Huong Phan; Duc Hoan Tran; Ngoc Thach Pham; Van Phai Dam; Thi Lan Nguyen; Aruna Ambagala; Shawn Babiuk; Van Phan Le
Journal:  Arch Virol       Date:  2022-07-13       Impact factor: 2.685

Review 3.  Lumpy skin disease, an emerging transboundary viral disease: A review.

Authors:  Fatemeh Namazi; Azizollah Khodakaram Tafti
Journal:  Vet Med Sci       Date:  2021-02-01

4.  Mathematical modelling and evaluation of the different routes of transmission of lumpy skin disease virus.

Authors:  Reuma Magori-Cohen; Yoram Louzoun; Yael Herziger; Eldad Oron; Alon Arazi; Eeva Tuppurainen; Nahum Y Shpigel; Eyal Klement
Journal:  Vet Res       Date:  2012-01-11       Impact factor: 3.683

5.  Comparative Evaluation of Lumpy Skin Disease Virus-Based Live Attenuated Vaccines.

Authors:  Andy Haegeman; Ilse De Leeuw; Laurent Mostin; Willem Van Campe; Laetitia Aerts; Estelle Venter; Eeva Tuppurainen; Claude Saegerman; Kris De Clercq
Journal:  Vaccines (Basel)       Date:  2021-05-08

6.  Investigation of Post Vaccination Reactions of Two Live Attenuated Vaccines against Lumpy Skin Disease of Cattle.

Authors:  Zahra Bamouh; Jihane Hamdi; Siham Fellahi; Slimane Khayi; Mohammed Jazouli; Khalid Omari Tadlaoui; Ouafaa Fassi Fihri; Eeva Tuppurainen; Mehdi Elharrak
Journal:  Vaccines (Basel)       Date:  2021-06-08

7.  Mechanical transmission of lumpy skin disease virus by Rhipicephalus appendiculatus male ticks.

Authors:  E S M Tuppurainen; J C Lubinga; W H Stoltsz; M Troskie; S T Carpenter; J A W Coetzer; E H Venter; C A L Oura
Journal:  Epidemiol Infect       Date:  2012-04-30       Impact factor: 4.434

8.  Incidence and molecular characterisation of lumpy skin disease virus in Zimbabwe using the P32 gene.

Authors:  Prettimore Mafirakureva; Bamusi Saidi; Joshua Mbanga
Journal:  Trop Anim Health Prod       Date:  2016-09-26       Impact factor: 1.893

9.  Characterization of sheep pox virus vaccine for cattle against lumpy skin disease virus.

Authors:  Eeva S M Tuppurainen; Caroline R Pearson; Katarzyna Bachanek-Bankowska; Nick J Knowles; Shadi Amareen; Lorraine Frost; Mark R Henstock; Charles E Lamien; Adama Diallo; Peter P C Mertens
Journal:  Antiviral Res       Date:  2014-06-25       Impact factor: 5.970

Review 10.  Review: Capripoxvirus Diseases: Current Status and Opportunities for Control.

Authors:  E S M Tuppurainen; E H Venter; J L Shisler; G Gari; G A Mekonnen; N Juleff; N A Lyons; K De Clercq; C Upton; T R Bowden; S Babiuk; L A Babiuk
Journal:  Transbound Emerg Dis       Date:  2015-11-13       Impact factor: 5.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.